Keynumbers for: Creative Antibiotics

 12/31/200812/31/20096/30/201012/31/20106/30/201112/31/20116/30/201212/31/2012
Number of months that the report spans661218612612
Total revenue (MSEK)0.700.020.650.600.090.090.000.05
Earnings before interest and taxes (EBIT) (MSEK)-3.87-6.26-11.17-17.04-6.5613.72-5.45-16.54
Pre tax profit (PTP) (MSEK)-3.87-6.26-11.17-17.040.09-12.98-5.41-16.22
Net Revenue (MSEK)-3.87-6.26-11.20-16.76-6.24-12.98-5.41-16.22
Earnings per share (SEK)-0.16-0.27-0.24-0.49-0.13-0.28-0.22-0.34
Dividend per share (SEK)--------
Owner's equity (MSEK)12.100.2437.8930.7724.5317.797.451.57
Fixed assets (MSEK)0.180.141.700.180.160.140.120.10
Intangible assets (MSEK)--------
Liquid assets (MSEK)18.327.2943.2641.3034.0929.0118.5112.51
Total shareholder equity and liabilities (MSEK)----34.2529.1518.6312.61
Long time debts including distributions (MSEK)5.005.005.007.947.947.947.947.94
Short term debt (MSEK)1.402.192.062.771.783.423.243.09
The share's ratio value (SEK)0.100.100.100.100.100.100.0150.015
Cash flow for the period (MSEK)----7.26-12.62-10.35-16.40
Number of shares (in millions)---47 000 80047 000 80047 000 80047 000 80047 000 800
Average number of employees10101089676

  • Danderydsgatan 10
  • 114 86 Stockholm
  • Telefon: 08 - 545 038 00
  • Fax: 08 - 611 35 62
  • info(snabel-a)aktietorget(punkt)se